Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Time for shareholder activism?

<< Previous

Bullboard Posts

Next >>

Comment by fox7mfon Mar 30, 2023 4:00pm

61 Views

Post# 35370197

RE:RE:RE:RE:RE:RE:RE:Time for shareholder activism?

Coffey, Parsons & the rest of the BOD need to create shareholder value, like they said they would. They need to get the MC up to what it should be for a biotech that's supposedly set to embark of two ph3's this yr ($1.5b-$2b usd.) We need a healthy market cap sometime between the AGM & ASCO or we'll get pittance in any business development deal. GLTA.

<< Previous

Bullboard Posts

Next >>

Unsung profits: Three microcap stocks with a strong case for value